{
  "Q0": "Whole Genome Sequencing (WGS)",
  "Q1": "Not specified",
  "Q2": "No",
  "Q3": "No",
  "Q4": "No",
  "Q5": "No",
  "Q6": "No",
  "Q7": "No",
  "Q8": "Yes",
  "Q8.1": "Chromosomal Microarray Analysis (CMA)",
  "Q9": "Yes",
  "Q9.1": "No",
  "Q10": "No",
  "Q10.1": "Diagnostic",
  "Q11": "Not specified",
  "Q12": "No",
  "Q13": "Not specified",
  "Q14": "Not listed",
  "Q15": "No",
  "Q16": "No",
  "Q17": "The policy requires establishing a molecular diagnosis of an inheritable disease with appropriate documentation of medical necessity. Prior to WGS, more targeted testing such as chromosomal microarray should be completed. The test should be ordered by an appropriate specialist, not a non-MD neuropsychologist. Documentation should include how test results will impact clinical management.",
  "match": false
}